Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer
Clinical trial NCT04799431 · WITHDRAWN
Trial details
- NCT number
- NCT04799431
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-03
- Primary completion
- 2023-05-03
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.